Investing.com - Celgene (NASDAQ:CELG) reported fourth quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $2.39 on revenue of $4.04B. Analysts polled by Investing.com anticipated EPS of $2.32 on revenue of $3.99B. That compared to EPS of $2 on revenue of $3.48B in the same period a year earlier. The company had reported EPS of $2.29 on revenue of $3.89B in the previous quarter.
Celgene shares lost 0.41% to trade at $87.70 in pre-market trade following the report.
Celgene follows other major Healthcare sector earnings this month
On January 22, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings matched analyst's expectations on Tuesday, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.64 on revenue of $13.96B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar